company background image
688098 logo

Shanghai Shen Lian Biomedical SHSE:688098 Stock Report

Last Price

CN¥5.47

Market Cap

CN¥2.2b

7D

-5.7%

1Y

-32.5%

Updated

27 Mar, 2024

Data

Company Financials

Shanghai Shen Lian Biomedical Corporation

SHSE:688098 Stock Report

Market Cap: CN¥2.2b

688098 Stock Overview

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China.

688098 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health5/6
Dividends1/6

Shanghai Shen Lian Biomedical Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shanghai Shen Lian Biomedical
Historical stock prices
Current Share PriceCN¥5.47
52 Week HighCN¥8.34
52 Week LowCN¥4.18
Beta0.68
1 Month Change-2.50%
3 Month Change-26.48%
1 Year Change-32.47%
3 Year Change-57.13%
5 Year Changen/a
Change since IPO-85.14%

Recent News & Updates

Recent updates

Shareholder Returns

688098CN PharmaceuticalsCN Market
7D-5.7%-4.3%-4.9%
1Y-32.5%-11.8%-16.6%

Return vs Industry: 688098 underperformed the CN Pharmaceuticals industry which returned -11.4% over the past year.

Return vs Market: 688098 underperformed the CN Market which returned -14.8% over the past year.

Price Volatility

Is 688098's price volatile compared to industry and market?
688098 volatility
688098 Average Weekly Movement8.0%
Pharmaceuticals Industry Average Movement7.0%
Market Average Movement8.2%
10% most volatile stocks in CN Market11.5%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 688098's share price has been volatile over the past 3 months.

Volatility Over Time: 688098's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001365Xu Gaohttps://www.slbio.com.cn

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.

Shanghai Shen Lian Biomedical Corporation Fundamentals Summary

How do Shanghai Shen Lian Biomedical's earnings and revenue compare to its market cap?
688098 fundamental statistics
Market capCN¥2.25b
Earnings (TTM)CN¥31.52m
Revenue (TTM)CN¥301.49m

71.3x

P/E Ratio

7.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688098 income statement (TTM)
RevenueCN¥301.49m
Cost of RevenueCN¥0
Gross ProfitCN¥301.49m
Other ExpensesCN¥269.97m
EarningsCN¥31.52m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 27, 2024

Earnings per share (EPS)0.077
Gross Margin100.00%
Net Profit Margin10.45%
Debt/Equity Ratio0.08%

How did 688098 perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

128%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.